Literature DB >> 30905290

Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.

B N J Watson1, R A Easingwood2, B Tong1, M Wolf3, G P C Salmond4, R H J Staals1,5, M Bostina1,2, P C Fineran1,6.   

Abstract

CRISPR-Cas systems provide bacteria and archaea with adaptive immunity against genetic invaders, such as bacteriophages. The systems integrate short sequences from the phage genome into the bacterial CRISPR array. These 'spacers' provide sequence-specific immunity but drive natural selection of evolved phage mutants that escape the CRISPR-Cas defence. Spacer acquisition occurs by either naive or primed adaptation. Naive adaptation typically results in the incorporation of a single spacer. By contrast, priming is a positive feedback loop that often results in acquisition of multiple spacers, which occurs when a pre-existing spacer matches the invading phage. We predicted that single and multiple spacers, representative of naive and primed adaptation, respectively, would cause differing outcomes after phage infection. We investigated the response of two phages, ϕTE and ϕM1, to the Pectobacterium atrosepticum type I-F CRISPR-Cas system and observed that escape from single spacers typically occurred via point mutations. Alternatively, phages escaped multiple spacers through deletions, which can occur in genes encoding structural proteins. Cryo-EM analysis of the ϕTE structure revealed shortened tails in escape mutants with tape measure protein deletions. We conclude that CRISPR-Cas systems can drive phage genetic diversity, altering morphology and fitness, through selective pressures arising from naive and primed acquisition events. This article is part of a discussion meeting issue 'The ecology and evolution of prokaryotic CRISPR-Cas adaptive immune systems'.

Entities:  

Keywords:  CRISPR-Cas; bacteriophages; phage evolution; phage morphology; tape measure protein

Year:  2019        PMID: 30905290      PMCID: PMC6452268          DOI: 10.1098/rstb.2018.0090

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  57 in total

1.  Experimental evolution yields hundreds of mutations in a functional viral genome.

Authors:  J J Bull; M R Badgett; D Rokyta; I J Molineux
Journal:  J Mol Evol       Date:  2003-09       Impact factor: 2.395

Review 2.  Bacteriophages: evolution of the majority.

Authors:  Roger W Hendrix
Journal:  Theor Popul Biol       Date:  2002-06       Impact factor: 1.570

3.  DNA sequences of the tail fiber genes of bacteriophage P2: evidence for horizontal transfer of tail fiber genes among unrelated bacteriophages.

Authors:  E Haggård-Ljungquist; C Halling; R Calendar
Journal:  J Bacteriol       Date:  1992-03       Impact factor: 3.490

4.  CRISPR provides acquired resistance against viruses in prokaryotes.

Authors:  Rodolphe Barrangou; Christophe Fremaux; Hélène Deveau; Melissa Richards; Patrick Boyaval; Sylvain Moineau; Dennis A Romero; Philippe Horvath
Journal:  Science       Date:  2007-03-23       Impact factor: 47.728

Review 5.  CRISPR-Cas: Adapting to change.

Authors:  Simon A Jackson; Rebecca E McKenzie; Robert D Fagerlund; Sebastian N Kieper; Peter C Fineran; Stan J J Brouns
Journal:  Science       Date:  2017-04-06       Impact factor: 47.728

6.  Deletion formation in bacteriophage T4.

Authors:  B S Singer; J Westlye
Journal:  J Mol Biol       Date:  1988-07-20       Impact factor: 5.469

7.  Spontaneous deletion mutants of the Lactococcus lactis temperate bacteriophage BK5-T and localization of the BK5-T attP site.

Authors:  J D Boyce; B E Davidson; A J Hillier
Journal:  Appl Environ Microbiol       Date:  1995-11       Impact factor: 4.792

8.  Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system.

Authors:  Raymond H J Staals; Simon A Jackson; Ambarish Biswas; Stan J J Brouns; Chris M Brown; Peter C Fineran
Journal:  Nat Commun       Date:  2016-10-03       Impact factor: 14.919

9.  Unexpected evolutionary benefit to phages imparted by bacterial CRISPR-Cas9.

Authors:  Pan Tao; Xiaorong Wu; Venigalla Rao
Journal:  Sci Adv       Date:  2018-02-14       Impact factor: 14.136

10.  Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity.

Authors:  Mariann Landsberger; Sylvain Gandon; Sean Meaden; Clare Rollie; Anne Chevallereau; Hélène Chabas; Angus Buckling; Edze R Westra; Stineke van Houte
Journal:  Cell       Date:  2018-07-19       Impact factor: 41.582

View more
  6 in total

1.  The ecology and evolution of microbial CRISPR-Cas adaptive immune systems.

Authors:  Edze R Westra; Stineke van Houte; Sylvain Gandon; Rachel Whitaker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 2.  Evolutionary Ecology and Interplay of Prokaryotic Innate and Adaptive Immune Systems.

Authors:  Tatiana Dimitriu; Mark D Szczelkun; Edze R Westra
Journal:  Curr Biol       Date:  2020-10-05       Impact factor: 10.834

Review 3.  The arms race between bacteria and their phage foes.

Authors:  Hannah G Hampton; Bridget N J Watson; Peter C Fineran
Journal:  Nature       Date:  2020-01-15       Impact factor: 49.962

4.  Searching for fat tails in CRISPR-Cas systems: Data analysis and mathematical modeling.

Authors:  Yekaterina S Pavlova; David Paez-Espino; Andrew Yu Morozov; Ilya S Belalov
Journal:  PLoS Comput Biol       Date:  2021-03-26       Impact factor: 4.475

Review 5.  It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.

Authors:  Edze R Westra; Bruce R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-29       Impact factor: 11.205

6.  Two Lineages of Pseudomonas aeruginosa Filamentous Phages: Structural Uniformity over Integration Preferences.

Authors:  Krzysztof Fiedoruk; Magdalena Zakrzewska; Tamara Daniluk; Ewelina Piktel; Sylwia Chmielewska; Robert Bucki
Journal:  Genome Biol Evol       Date:  2020-10-01       Impact factor: 3.416

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.